TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15274152

Group type: EXPERIMENTAL
Intervention: Combined fibrinolysis with 50 mg of alteplase and abciximab (n = 34)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Primary angioplasty with adjunctive abciximab (n = 36)
Number of subjects: 70
Study: 11260099

Group type: EXPERIMENTAL
Intervention: Loop Transverse Colostomy (LTC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Loop Ileostomy (LI)
Number of subjects: 70
Study: 9704725

Group type: EXPERIMENTAL
Intervention: 50 mg mitomycin bound to a solution of 375 mg carbo adsorbens intraperitoneally before closure of the abdominal wound (n = 46)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Surgical control group (n = 45)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: M-CH therapy
Number of subjects: 91
Study: 8208399

Group type: EXPERIMENTAL
Intervention: Low serum concentration of 4-aminopyridine (30 to 59 ng/ml)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High serum concentration of 4-aminopyridine (60 to 100 ng/ml)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2536599

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) administered at 15 ng/kg/min for hour 1 and 50 ng/kg/min for hour 2, preceded by a 50-micrograms bolus
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31630600

Group type: EXPERIMENTAL
Intervention: Alalfy modified cervical inversion technique plus hemostatic sutures
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (hemostatic sutures only)
Number of subjects: 240
Study: 31915178

Group type: EXPERIMENTAL
Intervention: Fast breathing pneumonia recurrence
Number of subjects: 4003

Group type: EXPERIMENTAL
Intervention: Poor-quality housing (katcha or mixed type)
Number of subjects: 4003

Group type: EXPERIMENTAL
Intervention: Environmental predictors (housing type, indoor air quality, etc.)
Number of subjects: 4003
Study: 31197095

Group type: EXPERIMENTAL
Intervention: High cadence cycling (3 sessions on a custom motorized stationary ergometer)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 35
Study: 29059017

Group type: EXPERIMENTAL
Intervention: Health information technology (HIT) diabetes self‐management education (DSME) intervention, including a 1-time training session lasting 73.6 minutes and additional on-site sessions based on need.
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Basic technology help and introduction to the Mobile Diabetes Detective (MoDD) website and text message features.
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: On-site visits for usual care were collected as part of the intervention.
Number of subjects: 220
Study: 25491276

Group type: EXPERIMENTAL
Intervention: Intra-articular platelet-rich plasma (PRP) injection
Number of subjects: 20

Group type: COMPARATOR
Intervention: Arthrocentesis
Number of subjects: 20
Study: 24317850

Group type: EXPERIMENTAL
Intervention: Antitumor treatment
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Higher spiritual well‐being scores
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Higher spiritual well‐being
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Religiousness
Number of subjects: 196

Group type: COMPARATOR
Intervention: Race
Number of subjects: 196
Study: 22491380

Group type: EXPERIMENTAL
Intervention: Toothbrushing frequency
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Socioeconomic status
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: External locus of control
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: IQPI
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: IQPI and gender
Number of subjects: 237
Study: 19469186

Group type: EXPERIMENTAL
Intervention: New therapeutic approaches targeting TRPV1 receptors, cytokine receptors, neuropeptide receptors, glutamate receptors, sodium and calcium channels.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Understanding of neuronal mechanisms of placebo effects.
Number of subjects: 0
Study: 17767819

Group type: EXPERIMENTAL
Intervention: Mechanical respiratory frequency set at 5, 10, 15, and 20 breaths per minute
Number of subjects: 12
Study: 15881485

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day (RLX)
Number of subjects: 5133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5133
Study: 12450717

Group type: EXPERIMENTAL
Intervention: OptiBond FL (OB) with immediate placement (IP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1 (PB) with immediate placement (IP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: OptiBond FL (OB) with delayed placement (DP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.1 (PB) with delayed placement (DP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 8
Study: 10510990

Group type: EXPERIMENTAL
Intervention: Cilostazol, 100 mg, twice a day
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Cilostazol, 50 mg, twice a day
Number of subjects: 516

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 516
Study: 7862386

Group type: EXPERIMENTAL
Intervention: Heparin sodium (100 U/mL)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal saline (0.9% sodium chloride)
Number of subjects: 64
Study: 2018339

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 33 micrograms/hr fentanyl for 48 hours in group X
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with 33 micrograms/hr fentanyl for 48 hours in group Y
Number of subjects: 27
Study: 7056864

Group type: EXPERIMENTAL
Intervention: Fake good instruction
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Fake bad instruction
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Fake average instruction
Number of subjects: 240

Group type: COMPARATOR
Intervention: Actual feelings (trial 1)
Number of subjects: 240
Study: 30758289

Group type: EXPERIMENTAL
Intervention: Technology-based supportive educational parenting program (SEPP)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Routine perinatal care (Control)
Number of subjects: 236
Study: 27896921

Group type: EXPERIMENTAL
Intervention: Iron supplementation (27 mg of iron)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Iron supplementation (Fe-B group)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Iron groups combined
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Iron groups (among women without elevated CRP)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Iron groups
Number of subjects: 114
Study: 26498958

Group type: COMPARATOR
Intervention: Arthroscopic acromioplasty (AA) alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arthroscopic acromioplasty (AA) with autologous PRP injection (AA + PRP)
Number of subjects: 60
Study: 23485610

Group type: EXPERIMENTAL
Intervention: Extended-release carbidopa-levodopa
Number of subjects: 471

Group type: COMPARATOR
Intervention: Immediate-release carbidopa-levodopa
Number of subjects: 471
Study: 21464888

Group type: EXPERIMENTAL
Intervention: Probation Case Management (PCM)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Standard Probation
Number of subjects: 183
Study: 19289487

Group type: EXPERIMENTAL
Intervention: Wolf Motor Function Test (WMFT) performance time
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Wolf Motor Function Test (WMFT) functional ability scale (FAS)
Number of subjects: 57
Study: 17317877

Group type: EXPERIMENTAL
Intervention: 0.9% saline intravenous
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.45% saline intravenous
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.45% saline oral
Number of subjects: 8

Group type: COMPARATOR
Intervention: No Rehy (no fluid)
Number of subjects: 8
Study: 15548244

Group type: EXPERIMENTAL
Intervention: Sustained-release morphine sulfate (SRMS) 30 mg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 11496941

Group type: EXPERIMENTAL
Intervention: Transdermal oxybutynin (OXY) administered via a single transdermal system over a 96 h wear period
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral oxybutynin (OXY) administered as a single 5 mg immediate-release tablet
Number of subjects: 18
Study: 9603587

Group type: EXPERIMENTAL
Intervention: Hypocapneic group
Number of subjects: 19

Group type: COMPARATOR
Intervention: Eucapneic group
Number of subjects: 19
Study: 8172137

Group type: EXPERIMENTAL
Intervention: 1 MU of L-IFN
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3 MU of L-IFN
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3 MU of L-IFN (24 weeks after stopping treatment)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1 MU of L-IFN (24 weeks after stopping treatment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (24 weeks after stopping treatment)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both treatment groups (2',5'-Oligoadenylate synthetase activities)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3 MU of L-IFN (anti-HCV titers)
Number of subjects: 30
Study: 3293631

Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs
Number of subjects: 551

Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 551
Study: 30454042

Group type: EXPERIMENTAL
Intervention: Continuous landiolol infusion to reach a target HR of 80-94 bpm along with standard treatment according to the Surviving Sepsis Campaign Guidelines 2016
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 200
Study: 28027332

Group type: EXPERIMENTAL
Intervention: 25 mg/d opicapone
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: 50 mg/d opicapone
Number of subjects: 427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study: 26122504

Group type: EXPERIMENTAL
Intervention: MON-400BUD (low-dose inhaled budesonide + montelukast)
Number of subjects: 128

Group type: COMPARATOR
Intervention: 800BUD (medium-dose inhaled budesonide)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: MON-400BUD
Number of subjects: 128

Group type: COMPARATOR
Intervention: 800BUD
Number of subjects: 128
Study: 23316693

Group type: EXPERIMENTAL
Intervention: Hyperinsulinaemic hyperglycaemic clamp (50 m-units·m⁻²·min⁻¹, 10 mmol/l)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hyperglycaemic euinsulinaemic clamp (10 mmol/l, 5 m-units·m⁻²·min⁻¹)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hyperinsulinaemic euglycaemic clamp (50 m-units·m⁻²·min⁻¹, 4.5 mmol/l)
Number of subjects: 7
Study: 21464451

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 18
Study: 19589290

Group type: EXPERIMENTAL
Intervention: Intranasal flunisolide
Number of subjects: 178

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 178
Study: 16916809

Group type: EXPERIMENTAL
Intervention: Telephone counselling by a pharmacist
Number of subjects: 502

Group type: COMPARATOR
Intervention: Control group (no telephone counselling)
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Overall cohort analysis
Number of subjects: 502
Study: 15593188

Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 122
Study: 11333074

Group type: EXPERIMENTAL
Intervention: High reactivity and high reliance on mother during emotion challenges
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: High fearful distress and low reliance on mother
Number of subjects: 518
Study: 9149585

Group type: EXPERIMENTAL
Intervention: Normothermic (warm) technique
Number of subjects: 331

Group type: COMPARATOR
Intervention: Hypothermic (cold) technique
Number of subjects: 331
Study: 7898968

Group type: EXPERIMENTAL
Intervention: End-inspiratory occlusion (TGVl)
Number of subjects: 15

Group type: COMPARATOR
Intervention: End-expiratory occlusion (TGVE)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Airway resistance (R(aw))
Number of subjects: 15
Study: 2646255

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus misonidazole (RT + MISO)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Radiotherapy only (RT)
Number of subjects: 40
Study: 5774077

Group type: EXPERIMENTAL
Intervention: New technique of ascending functional cinephlebography
Number of subjects: 22

Group type: COMPARATOR
Intervention: Delayed diagnosis
Number of subjects: 22
Study: 31165717

Group type: EXPERIMENTAL
Intervention: SmokefreeTXT (SMS text messaging service)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no SMS text messaging service)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SmokefreeTXT
Number of subjects: 50
Study: 28506003

Group type: EXPERIMENTAL
Intervention: Bilateral EMG-triggered multi-channel electrostimulation + mirror therapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Bilateral EMG-triggered multi-channel electrostimulation
Number of subjects: 33
Study: 25623822

Group type: EXPERIMENTAL
Intervention: Bereavement follow-up intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Greater support from healthcare professionals
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Mothers' age, self-perceived health status, and age of deceased child
Number of subjects: 136
Study: 23506170

Group type: EXPERIMENTAL
Intervention: Insecticide-treated nets (ITNs) distributed to treatment group households
Number of subjects: 39963
Study: 21439047

Group type: EXPERIMENTAL
Intervention: Tailored implementation programme for CHF management
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standardised way of delivering the programme
Number of subjects: 60
Study: 18535605

Group type: EXPERIMENTAL
Intervention: Bimatoprost/timolol fixed combination (BTFC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Latanoprost/timolol fixed combination (LTFC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: LTFC
Number of subjects: 54
Study: 16420196

Group type: EXPERIMENTAL
Intervention: Nonpharmacological intervention including daytime physical activity, evening bright light exposure, consistent bedtime routine, nighttime care routines, strategies to reduce nighttime noise.
Number of subjects: 273

Group type: COMPARATOR
Intervention: Control group (Group 2) received no intervention initially.
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Polysomnography in a subgroup of 45 subjects.
Number of subjects: 273
Study: 15279042

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 227

Group type: COMPARATOR
Intervention: First generation antipsychotic medications
Number of subjects: 227
Study: 11225716

Group type: EXPERIMENTAL
Intervention: Obese patients without OSAS
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Obese patients with OSAS
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Obese patients with OHS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 25
Study: 8843207

Group type: EXPERIMENTAL
Intervention: Nevirapine at doses > or = 240 mg/m2/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 21
Study: 1292918

Group type: EXPERIMENTAL
Intervention: L-carnitine (4 g/day for 12 months)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 6828970

Group type: EXPERIMENTAL
Intervention: 2 gram intravenous bolus dose of cefamandole
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no cefamandole)
Number of subjects: 102
Study: 31177391

Group type: EXPERIMENTAL
Intervention: HERMES intervention
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group (delayed intervention)
Number of subjects: 199
Study: 30418963

Group type: EXPERIMENTAL
Intervention: Exclusive double poling (DP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Classic techniques (CLASSIC)
Number of subjects: 19
Study: 29259310

Group type: EXPERIMENTAL
Intervention: rhIL-2 injection
Number of subjects: 271
Study: 26586249

Group type: EXPERIMENTAL
Intervention: Responses to 34 questions on a 5-point Likert scale regarding barriers to following the hemodialysis diet
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Duration of hemodialysis
Number of subjects: 140
Study: 24955674

Group type: EXPERIMENTAL
Intervention: Computer-delivered, home-based, alcohol-specific attention modification program (AMP)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Attention control condition (ACC)
Number of subjects: 41
Study: 22965960

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 20190918

Group type: EXPERIMENTAL
Intervention: Information phase for 5 nursing staff
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Video scoring phase for all 6 nursing staff
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Safety feedback phase for 2 participants
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Treatment withdrawal for all participants
Number of subjects: 6
Study: 17721095

Group type: EXPERIMENTAL
Intervention: Memantine (10 mg daily escalated to 40 mg daily for 16 weeks)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 15513282

Group type: COMPARATOR
Intervention: Triathletes
Number of subjects: 48

Group type: COMPARATOR
Intervention: Swimmers
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cyclists
Number of subjects: 48

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 48
Study: 11241253

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (3.75 g calcium carbonate daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 52
Study: 9558016

Group type: EXPERIMENTAL
Intervention: Protocol B (120 min/wk, 20 min x 2 per day, 3 days/wk)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Protocol C (120 min/wk, 20 min/day, 6 days/wk)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Protocol A (20 min/wk, 10 min/day, 2 days/wk)
Number of subjects: 24
Study: 8299916

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2543895

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (Estraderm)
Number of subjects: 0
Study: 29877724

Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Therapy as Usual (TAU)
Number of subjects: 156
Study: 28591133

Group type: EXPERIMENTAL
Intervention: bioavailable RC extract (RCE), providing 34 mg/d isoflavones and probiotics
Number of subjects: 62

Group type: COMPARATOR
Intervention: masked placebo formulation
Number of subjects: 62
Study: 25053650

Group type: EXPERIMENTAL
Intervention: Brief computerized reasoning training intervention
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control condition involving computer‐based activities of similar duration
Number of subjects: 101
Study: 23661240

Group type: EXPERIMENTAL
Intervention: PTHrP(1-36) 400 µg/day
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: PTHrP(1-36) 600 µg/day
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: PTH(1-34) 20 µg/day
Number of subjects: 105
Study: 21764469

Group type: EXPERIMENTAL
Intervention: Ivabradine up to 7.5mg bid
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Carvedilol/ivabradine up to 12.5/7.5mg bid
Number of subjects: 121

Group type: COMPARATOR
Intervention: Carvedilol up to 25mg bid
Number of subjects: 121
Study: 19716510

Group type: EXPERIMENTAL
Intervention: GuttaFlow
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sealapex
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sealer 26
Number of subjects: 30
Study: 16943456

Group type: EXPERIMENTAL
Intervention: High-fat meal (HF)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Low-fat meal (LF)
Number of subjects: 49
Study: 12505481

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 10917292

Group type: EXPERIMENTAL
Intervention: PICC catheter
Number of subjects: 63

Group type: COMPARATOR
Intervention: PIV catheter
Number of subjects: 63
Study: 9431774

Group type: EXPERIMENTAL
Intervention: Xomed Audiant Bone Conductor
Number of subjects: 0

Group type: COMPARATOR
Intervention: NobleBiocare HC200 bone‐anchored hearing aid (BAHA) implant
Number of subjects: 0
Study: 1559296

Group type: EXPERIMENTAL
Intervention: Levothyroxine (mean dose 2.82 +/- 0.6 micrograms/kg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no levothyroxine)
Number of subjects: 40
Study: 3891826

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31715140

Group type: EXPERIMENTAL
Intervention: Multiuser virtual reality (MU) therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Single-user virtual reality (SU) therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both MU and SU therapy
Number of subjects: 20
Study: 28277921

Group type: EXPERIMENTAL
Intervention: Dexamethasone (3 IM doses of 8 mg, 8 hours apart)
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Control (no dexamethasone)
Number of subjects: 1272
Study: 27806033

Group type: EXPERIMENTAL
Intervention: Arthrem® (ART) 150 mg twice-daily
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Arthrem® (ART)
Number of subjects: 34
Study: 24493730

Group type: EXPERIMENTAL
Intervention: XRT group (postoperative radiotherapy)
Number of subjects: 381

Group type: COMPARATOR
Intervention: non‐XRT group (no postoperative radiotherapy)
Number of subjects: 381
Study: 23295170

Group type: EXPERIMENTAL
Intervention: Monetary incentives ranging from $10 to $38.75 for meeting fitness-center use goals
Number of subjects: 117

Group type: COMPARATOR
Intervention: No treatment (control condition)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Monetary incentives
Number of subjects: 117
Study: 21358208

Group type: EXPERIMENTAL
Intervention: Weekly docetaxel (35 mg/m2, days 1, 8, and 15; q4w)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard docetaxel (75 mg/m2 every 3 weeks; q3w)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Standard arm (q3w)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Weekly arm (q1w)
Number of subjects: 242